Meta-Analysishigh evidence
Cardiovascular and prostate cancer risk associated to testosterone replacement therapy - a systematic review and meta-analysis of 41 randomized controlled trials.
International journal of impotence research·February 11, 2026·PMID 41673435
Why it mattersThis meta-analysis provides the most current pooled evidence on cardiovascular and prostate safety of testosterone therapy, addressing key concerns that influence prescribing decisions in men with hypogonadism.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled